HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Renxuan Huang Selected Research

gamitrinib-triphenylphosphonium

11/2021Suppressing TRAP1 sensitizes glioblastoma multiforme cells to temozolomide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Renxuan Huang Research Topics

Disease

3Neoplasms (Cancer)
10/2022 - 01/2021
3Glioma (Gliomas)
10/2022 - 01/2021
2Glioblastoma (Glioblastoma Multiforme)
01/2022 - 11/2021
1Stroke (Strokes)
12/2021
1Ischemic Stroke
12/2021
1Parkinson Disease (Parkinson's Disease)
10/2020

Drug/Important Bio-Agent (IBA)

2Temozolomide (Temodar)FDA LinkGeneric
01/2022 - 11/2021
2LuteolinIBA
12/2021 - 01/2021
1AntioxidantsIBA
10/2022
1Therapeutic UsesIBA
12/2021
1FlavonoidsIBA
12/2021
1TNF Receptor-Associated Factor 1IBA
11/2021
1Small Interfering RNA (siRNA)IBA
11/2021
1gamitrinib-triphenylphosphoniumIBA
11/2021
1Pharmaceutical PreparationsIBA
01/2021
1PTEN-induced putative kinaseIBA
10/2020

Therapy/Procedure

2Therapeutics
10/2022 - 11/2021
2Drug Therapy (Chemotherapy)
01/2022 - 11/2021
1Chinese Traditional Medicine (Traditional Chinese Medicine)
12/2021
1Adjuvant Radiotherapy
11/2021